Research-Grade Peptides | 99%+ Purity Verified | US Delivery 2–5 Days
Save 5% with Crypto
SaiyanMed

Your Cart

No products in the cart.

Melanotan II vs PT-141: Receptor Selectivity in Research

Melanotan II and PT-141 (bremelanotide) are both melanocortin receptor peptides derived from alpha-MSH, but they differ significantly in receptor selectivity and research applications.

Melanocortin Receptor System

The melanocortin receptor family (MC1R through MC5R) mediates diverse physiological functions. Melanotan II is a non-selective agonist that binds to multiple subtypes, particularly MC1R (pigmentation) and MC4R. PT-141 was designed to preferentially activate MC4R and MC3R while reducing MC1R-mediated effects.

Structural Relationship

PT-141 is a metabolite of Melanotan II. The cyclic lactam structure of MT-II is preserved in PT-141 but with modifications that alter receptor binding selectivity. This metabolic relationship explains their overlapping but distinct pharmacological profiles.

Research Context

Melanotan II research focuses on pigmentation pathways and UV-protective melanogenesis. PT-141 research centers on central MC4R-mediated pathways. Both peptides have been studied in multiple preclinical models.